Biotinylated Mouse ALCAM/CD166 Protein, Active
Beta LifeScience
SKU/CAT #: BLK-02764P-100UG
Biotinylated Mouse ALCAM on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Biotinylated Mouse ALCAM/CD166 Protein, Active
Beta LifeScience
SKU/CAT #: BLK-02764P-100UG
Collections: Fc receptors, Other recombinant proteins, Recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Biotinylated Mouse ALCAM/CD166 Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus.It contains Tyr28-Lys527. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | Q61490 |
Target Symbol | ALCAM/CD166 |
Synonyms | CD166; ALCAM; MEMD; CD6L; KG-CAM |
Species | Mouse |
Expression System | HEK293 |
Tag | C-His-Avi |
Expression Range | Tyr28-Lys527 |
Mol. Weight | The protein has a predicted MW of 58.9 kDa. Due to glycosylation, the protein migrates to 75-85 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Activity | Immobilized Human CD6, His Tag at 1ug/ml (100ul/well) on the plate. Dose response curve for Biotinylated Mouse ALCAM, His Tag with the EC50 of 1.12ug/ml determined by ELISA. Contact us for detailed testing images. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | Brain metastasis (BM) in non-small-cell lung cancer (NSCLC) has a very poor prognosis. Recent studies have demonstrated the importance of cell adhesion molecules in tumor metastasis.Elevated levels of ALCAM expression promote BM formation in NSCLC through increased tumor cell dissemination and interaction with the brain endothelial cells. Therefore, ALCAM could be targeted to reduce the occurrence of BM. |